Arvee Laboratories (India) Ltd.

•
₹ 165.81-1.5%

2026-08-21

arveelabs.comBSE: -NSE: ARVEE
Market Cap₹ 192 Cr.
Current Price₹ 168
High / Low₹ 291 / 129
Stock P/E0.0
Book Value₹ 32
Price to Book5.01
Dividend Yield0.00 %
ROCE10.0 %
ROE7.1 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company is almost debt free
  • Company comfortably covers its interest (12.6x coverage)
  • Company generates healthy free cash flow

CONS

  • Operating cash flow has been negative in recent years
  • Company has a low return on equity of 8.9% over last 3 years
  • Company's sales have been declining over the last five years
  • Company has delivered a poor profit growth of -1.4% over past five years
  • Operating margins have contracted to 9.4% from 15.2%
  • Stock is trading at 5.0x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
ChemicalsChemicalsChemicals
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SOLARINDS19800.0089.97179170.310.06666.3788.983668.2070.2638.1627.91
2.PIDILITIND1650.0063.40167935.411.308835.101202.8645515.501112.7432.3826.28
3.SRF2575.0035.3176329.390.35758.8775.535033.2634.6314.2124.57
4.FLUOROCHEM4679.5583.5951404.860.06219.0019.021588.0023.9710.0226.83
5.NAVINFLUOR8281.5053.8042484.110.18243.31107.671045.0844.0721.3934.17
6.GODREJIND1217.1034.8740998.140.00523.36-27.855448.0922.1610.6412.82
7.DEEPAKNTR1767.8530.7824112.240.42345.01207.362577.6036.3911.5820.96
8.AETHER1639.4092.5221759.400.0062.7533.45326.5627.4911.6531.47
9.ATUL6581.7524.3619377.830.46253.9391.851847.9525.0315.0521.41
10.AARTIIND526.9035.9919112.070.19155.00260.472387.0042.426.3916.00
11.DEEPAKFERT1474.6518.9818678.340.68490.04100.953256.2622.4712.1225.96
12.ARVEE174.390.00192.180.001.69896.4717.23130.2810.0014.49
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
8
7
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
24.62%
Net Profit
0
0
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Sep 2023
9
8
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
25.00%
Net Profit
0
0
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Dec 2023
8
7
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
25.00%
Net Profit
0
0
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Mar 2024
6
5
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
79.31%
Net Profit
0
0
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
18
Promoter Pledge %
0.00%
Jun 2024
11
9
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
25.40%
Net Profit
1
1
Equity Capital
11
Reserves
19
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
19
Promoter Pledge %
0.00%
Sep 2024
13
11
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
25.19%
Net Profit
1
1
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Dec 2024
9
9
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
23.81%
Net Profit
0
0
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Mar 2025
6
6
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
33.33%
Net Profit
0
0
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Jun 2025
7
7
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
5.88%
Net Profit
0
0
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Sep 2025
3
3
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
0
Tax %
0.00%
Net Profit
0
0
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
20
Promoter Pledge %
0.00%
Dec 2025
10
8
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
-31.65%
Net Profit
2
2
Equity Capital
11
Reserves
23
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
23
Promoter Pledge %
0.00%
Mar 2026
11
10
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
38.82%
Net Profit
1
0
Equity Capital
11
Reserves
23
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
23
Promoter Pledge %
0.00%
Jun 2026
17
15
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
2
Tax %
25.99%
Net Profit
2
0
Equity Capital
11
Reserves
24
Promoter Pledge %
0.00%
Equity Capital
11
Reserves
24
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
27
22
Operating Profit
5
OPM %
19
Other Income
0
Interest
3
Depreciation
1
1
Tax %
65
Net Profit
0
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Mar 2017
34
29
Operating Profit
6
OPM %
19
Other Income
1
Interest
3
Depreciation
2
1
Tax %
-80
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2018
48
41
Operating Profit
7
OPM %
15
Other Income
0
Interest
3
Depreciation
2
2
Tax %
43
Net Profit
1
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2019
55
49
Operating Profit
7
OPM %
12
Other Income
0
Interest
2
Depreciation
2
3
Tax %
11
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2020
45
39
Operating Profit
6
OPM %
14
Other Income
0
Interest
1
Depreciation
2
3
Tax %
26
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2021
47
41
Operating Profit
7
OPM %
14
Other Income
1
Interest
1
Depreciation
2
4
Tax %
26
Net Profit
3
EPS
3
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2022
40
35
Operating Profit
6
OPM %
15
Other Income
1
Interest
0
Depreciation
2
3
Tax %
25
Net Profit
3
EPS
2
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2023
61
54
Operating Profit
9
OPM %
14
Other Income
1
Interest
0
Depreciation
2
6
Tax %
33
Net Profit
4
EPS
4
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2024
30
27
Operating Profit
4
OPM %
12
Other Income
1
Interest
0
Depreciation
1
2
Tax %
43
Net Profit
1
EPS
1
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2025
38
35
Operating Profit
4
OPM %
11
Other Income
1
Interest
0
Depreciation
1
3
Tax %
25
Net Profit
2
EPS
2
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
TTM
41
36
Operating Profit
—
OPM %
—
Other Income
1
Interest
0
Depreciation
1
5
Tax %
11
Net Profit
4
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
11%
5 Years:
-3%
3 Years:
-2%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-1%
3 Years:
-6%

STOCK PRICE CAGR

10 Years:
—
5 Years:
11%
3 Years:
17%
1 Year:
4%

RETURN ON EQUITY

10 Years:
15%
5 Years:
10%
3 Years:
9%
Last Year:
7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2020

Oct 13

1:1

Mar 2016
Equity Capital
4
-1
6
Trade Payables
6
20
Total Liabilities
35
13
Capital Work in Progress
4
0
7
0
Cash & Bank
1
9
Total Assets
35
Total Debt
25
Net Working Capital
3
Contingent Liabilities
0
Book Value per Share
6.52
Face Value
10.00
Total Debt
25
Net Working Capital
3
Contingent Liabilities
0
Book Value per Share
6.52
Face Value
10.00
Mar 2017
Equity Capital
4
0
7
Trade Payables
6
18
Total Liabilities
36
17
Capital Work in Progress
0
0
6
0
Cash & Bank
1
12
Total Assets
36
Total Debt
25
Net Working Capital
4
Contingent Liabilities
0
Book Value per Share
10.36
Face Value
10.00
Total Debt
25
Net Working Capital
4
Contingent Liabilities
0
Book Value per Share
10.36
Face Value
10.00
Mar 2018
Equity Capital
6
9
7
Trade Payables
12
11
Total Liabilities
44
15
Capital Work in Progress
1
0
8
0
Cash & Bank
2
18
Total Assets
44
Total Debt
16
Net Working Capital
6
Contingent Liabilities
0
Book Value per Share
25.32
Face Value
10.00
Total Debt
16
Net Working Capital
6
Contingent Liabilities
0
Book Value per Share
25.32
Face Value
10.00
Mar 2019
Equity Capital
6
11
8
Trade Payables
6
7
Total Liabilities
37
13
Capital Work in Progress
2
2
5
0
Cash & Bank
4
12
Total Assets
37
Total Debt
13
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
29.53
Face Value
10.00
Total Debt
13
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
29.53
Face Value
10.00
Mar 2020
Equity Capital
6
13
2
Trade Payables
10
3
Total Liabilities
34
13
Capital Work in Progress
2
3
6
0
Cash & Bank
1
8
Total Assets
34
Total Debt
4
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
33.82
Face Value
10.00
Total Debt
4
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
33.82
Face Value
10.00
Mar 2021
Equity Capital
11
10
8
Trade Payables
10
2
Total Liabilities
41
14
Capital Work in Progress
1
2
7
0
Cash & Bank
7
10
Total Assets
41
Total Debt
9
Net Working Capital
7
Contingent Liabilities
0
Book Value per Share
19.39
Face Value
10.00
Total Debt
9
Net Working Capital
7
Contingent Liabilities
0
Book Value per Share
19.39
Face Value
10.00
Mar 2022
Equity Capital
11
13
2
Trade Payables
10
3
Total Liabilities
39
14
Capital Work in Progress
1
0
6
0
Cash & Bank
5
14
Total Assets
39
Total Debt
3
Net Working Capital
10
Contingent Liabilities
0
Book Value per Share
21.72
Face Value
10.00
Total Debt
3
Net Working Capital
10
Contingent Liabilities
0
Book Value per Share
21.72
Face Value
10.00
Mar 2023
Equity Capital
11
17
0
Trade Payables
8
3
Total Liabilities
39
13
Capital Work in Progress
2
0
5
0
Cash & Bank
1
19
Total Assets
39
Total Debt
1
Net Working Capital
13
Contingent Liabilities
0
Book Value per Share
25.46
Face Value
10.00
Total Debt
1
Net Working Capital
13
Contingent Liabilities
0
Book Value per Share
25.46
Face Value
10.00
Mar 2024
Equity Capital
11
18
0
Trade Payables
7
3
Total Liabilities
39
13
Capital Work in Progress
3
0
6
6
Cash & Bank
2
9
Total Assets
39
Total Debt
1
Net Working Capital
10
Contingent Liabilities
0
Book Value per Share
26.42
Face Value
10.00
Total Debt
1
Net Working Capital
10
Contingent Liabilities
0
Book Value per Share
26.42
Face Value
10.00
Mar 2025
Equity Capital
11
20
0
Trade Payables
3
3
Total Liabilities
38
15
Capital Work in Progress
1
0
5
8
Cash & Bank
5
4
Total Assets
38
Total Debt
1
Net Working Capital
16
Contingent Liabilities
0
Book Value per Share
28.37
Face Value
10.00
Total Debt
1
Net Working Capital
16
Contingent Liabilities
0
Book Value per Share
28.37
Face Value
10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
6
Cash from Investing
-5
Cash from Financing
-1
0
Free Cash Flow
2
OCF / Net Profit
33.23
Cumulative 5-Year FCF
0
OCF / Net Profit
33.23
Cumulative 5-Year FCF
0
Mar 2017
4
Cash from Investing
-1
Cash from Financing
-3
-0
Free Cash Flow
3
OCF / Net Profit
2.60
Cumulative 5-Year FCF
0
OCF / Net Profit
2.60
Cumulative 5-Year FCF
0
Mar 2018
6
Cash from Investing
-1
Cash from Financing
-4
1
Free Cash Flow
5
OCF / Net Profit
5.52
Cumulative 5-Year FCF
0
OCF / Net Profit
5.52
Cumulative 5-Year FCF
0
Mar 2019
9
Cash from Investing
-3
Cash from Financing
-5
2
Free Cash Flow
8
OCF / Net Profit
4.18
Cumulative 5-Year FCF
0
OCF / Net Profit
4.18
Cumulative 5-Year FCF
0
Mar 2020
10
Cash from Investing
-3
Cash from Financing
-10
-3
Free Cash Flow
8
OCF / Net Profit
4.49
Cumulative 5-Year FCF
25
OCF / Net Profit
4.49
Cumulative 5-Year FCF
25
Mar 2021
2
Cash from Investing
-1
Cash from Financing
5
6
Free Cash Flow
-0
OCF / Net Profit
0.64
Cumulative 5-Year FCF
23
OCF / Net Profit
0.64
Cumulative 5-Year FCF
23
Mar 2022
4
Cash from Investing
0
Cash from Financing
-6
-2
Free Cash Flow
2
OCF / Net Profit
1.56
Cumulative 5-Year FCF
22
OCF / Net Profit
1.56
Cumulative 5-Year FCF
22
Mar 2023
3
Cash from Investing
-1
Cash from Financing
-2
-1
Free Cash Flow
1
OCF / Net Profit
0.71
Cumulative 5-Year FCF
19
OCF / Net Profit
0.71
Cumulative 5-Year FCF
19
Mar 2024
4
Cash from Investing
-2
Cash from Financing
-0
1
Free Cash Flow
1
OCF / Net Profit
3.48
Cumulative 5-Year FCF
12
OCF / Net Profit
3.48
Cumulative 5-Year FCF
12
Mar 2025
-0
Cash from Investing
-1
Cash from Financing
-0
-2
Free Cash Flow
-2
OCF / Net Profit
-0.10
Cumulative 5-Year FCF
2
OCF / Net Profit
-0.10
Cumulative 5-Year FCF
2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
EPS (₹)
0.46
Book Value (₹)
6.52
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.07
Operating Margin %
18.99%
Net Margin %
0.70%
ROE %
9.24%
ROCE %
14.39%
0.61%
Debtor Days
52
Inventory Days
91
Payable Days
97
47
Debt to Equity (x)
9.59x
Interest Coverage (x)
1.17x
1.24x
Revenue Growth %
106.80%
Operating Profit Growth %
134.39%
Net Profit Growth %
111.38%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
3.83
Book Value (₹)
10.36
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.47
Operating Margin %
18.61%
Net Margin %
4.51%
ROE %
45.41%
ROCE %
15.19%
4.38%
Debtor Days
76
Inventory Days
70
Payable Days
99
47
Debt to Equity (x)
5.96x
Interest Coverage (x)
1.25x
1.26x
Revenue Growth %
28.35%
Operating Profit Growth %
25.78%
Net Profit Growth %
728.04%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
1.98
Book Value (₹)
25.32
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.94
Operating Margin %
15.49%
Net Margin %
2.28%
ROE %
12.01%
ROCE %
17.69%
2.73%
Debtor Days
91
Inventory Days
55
Payable Days
111
35
Debt to Equity (x)
1.16x
Interest Coverage (x)
1.58x
1.28x
Revenue Growth %
38.80%
Operating Profit Growth %
15.48%
Net Profit Growth %
-29.81%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
4.11
Book Value (₹)
29.53
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.19
Operating Margin %
11.89%
Net Margin %
4.12%
ROE %
14.97%
ROCE %
14.10%
5.57%
Debtor Days
78
Inventory Days
42
Payable Days
85
35
Debt to Equity (x)
0.79x
Interest Coverage (x)
2.56x
1.29x
Revenue Growth %
14.91%
Operating Profit Growth %
-11.77%
Net Profit Growth %
107.77%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
4.17
Book Value (₹)
33.82
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.16
Operating Margin %
14.02%
Net Margin %
5.06%
ROE %
13.17%
ROCE %
15.79%
6.50%
Debtor Days
58
Inventory Days
45
Payable Days
100
2
Debt to Equity (x)
0.21x
Interest Coverage (x)
4.13x
1.43x
Revenue Growth %
-17.27%
Operating Profit Growth %
-2.47%
Net Profit Growth %
1.60%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
2.43
Book Value (₹)
19.39
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.61
Operating Margin %
13.98%
Net Margin %
5.65%
ROE %
13.38%
ROCE %
15.99%
7.17%
Debtor Days
55
Inventory Days
54
Payable Days
121
-12
Debt to Equity (x)
0.42x
Interest Coverage (x)
7.32x
1.40x
Revenue Growth %
4.31%
Operating Profit Growth %
4.04%
Net Profit Growth %
16.46%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
2.34
Book Value (₹)
21.72
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.44
Operating Margin %
15.22%
Net Margin %
6.38%
ROE %
11.36%
ROCE %
13.33%
6.46%
Debtor Days
91
Inventory Days
60
Payable Days
158
-8
Debt to Equity (x)
0.13x
Interest Coverage (x)
10.31x
1.75x
Revenue Growth %
-14.88%
Operating Profit Growth %
-7.32%
Net Profit Growth %
-3.87%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
3.74
Book Value (₹)
25.46
Dividend per Share (₹)
0.00
Cash EPS (₹)
5.63
Operating Margin %
11.87%
Net Margin %
6.71%
ROE %
15.84%
ROCE %
23.35%
10.65%
Debtor Days
73
Inventory Days
31
Payable Days
82
21
Debt to Equity (x)
0.04x
Interest Coverage (x)
16.89x
2.44x
Revenue Growth %
52.12%
Operating Profit Growth %
40.61%
Net Profit Growth %
60.03%
60.03%
P/E (x)
23.54x
P/B (x)
3.46x
Dividend Yield %
0.00%
11.25x
Mar 2024
EPS (₹)
0.95
Book Value (₹)
26.42
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.31
Operating Margin %
9.68%
Net Margin %
3.47%
ROE %
3.68%
ROCE %
7.03%
2.72%
Debtor Days
111
Inventory Days
66
Payable Days
181
-4
Debt to Equity (x)
0.03x
Interest Coverage (x)
8.33x
2.38x
Revenue Growth %
-50.54%
Operating Profit Growth %
-58.57%
Net Profit Growth %
-74.46%
-74.46%
P/E (x)
150.24x
P/B (x)
5.43x
Dividend Yield %
0.00%
43.93x
Mar 2025
EPS (₹)
1.95
Book Value (₹)
28.37
Dividend per Share (₹)
0.00
Cash EPS (₹)
2.99
Operating Margin %
9.38%
Net Margin %
5.58%
ROE %
7.11%
ROCE %
10.00%
5.64%
Debtor Days
69
Inventory Days
52
Payable Days
87
33
Debt to Equity (x)
0.03x
Interest Coverage (x)
12.56x
5.14x
Revenue Growth %
26.83%
Operating Profit Growth %
19.31%
Net Profit Growth %
104.15%
104.15%
P/E (x)
72.87x
P/B (x)
5.01x
Dividend Yield %
0.00%
35.75x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Sep 2024
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Dec 2024
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Mar 2025
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Jun 2025
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Sep 2025
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Dec 2025
73.51
FIIs
0.00
DIIs
0.00
Government
0.00
26.49
Mar 2026
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50
Jun 2026
73.50
FIIs
0.00
DIIs
0.00
Government
0.00
26.50

Documents

Announcements

  • Outcome of Board Meeting

    2026-08-07 - Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Corrigendum

    2026-08-04 - Arvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

Nothing filed yet.